SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-031609
Filing Date
2023-11-13
Accepted
2023-11-13 16:06:01
Documents
15
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20231113_8k.htm   iXBRL 8-K 30929
2 EXHIBIT 99.1 ex_596186.htm EX-99.1 113447
7 cervomed01.jpg GRAPHIC 9004
  Complete submission text file 0001437749-23-031609.txt   303607

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crvo-20231113.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20231113_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20231113_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20231113_pre.xml EX-101.PRE 11585
9 EXTRACTED XBRL INSTANCE DOCUMENT crvo20231113_8k_htm.xml XML 2543
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 231398621
SIC: 2834 Pharmaceutical Preparations